French politics usually takes a break in August, but a row has blown up over tackling benefit fraud. The government has proposed stricter monitoring of claimants while the opposition has accused ministers of political posturing.

"/> French politics usually takes a break in August, but a row has blown up over tackling benefit fraud. The government has proposed stricter monitoring of claimants while the opposition has accused ministers of political posturing.

" />
SHARE
COPY LINK

XAVIER BERTRAND

Opposition slams government anti-fraud moves

French politics usually takes a break in August, but a row has blown up over tackling benefit fraud. The government has proposed stricter monitoring of claimants while the opposition has accused ministers of political posturing.

Despite most of France’s political classes being on their traditional August holidays, a proposal to get tough on benefit fraud by the transport minister has had a bigger impact than probably even he expected.

Thierry Mariani, a member of the conservative wing of the governing UMP party, was speaking to the Journal du Dimanche in a wide ranging interview.

When asked what themes he and his fellow right-wingers would focus on in the upcoming elections of 2012, Mariani listed a number of topics. 

“We will have a series of proposals on sovereignty, jobs and social justice. This is an important theme. It’s about fighting those who profit both at the bottom and the top of the social scale,” he told the newspaper.

Regarding benefit fraud, he said “I support the creation of one single register that lists all the benefits that are claimed. This will help identify abuse. At the moment, the same person can claim income support benefits in several areas because the lists aren’t linked together.”

“I am completely in agreement with Thierry Mariani,” employment minister Xavier Bertrand told AFP on Sunday.

“The creation of a single register covering all benefits, allowing us to check claims against each other, is the best way to reinforce the battle against benefit fraud,” he said. He promised the register would be in place before the end of the year.

Opposition politicians were quick to attack the measures. 

The proposal is intended to “stigmatize those people who are having a difficult time,” said Socialist politician Jean-Michel Baylet, who is standing in the upcoming primary race that will choose the party’s presidential candidate.

Benoît Hamon, Socialist party spokesman, used his Twitter account to make a comparison between the “€2 billion of benefit fraud” versus the “€8-16 billion euros” of fraud by employers in their payment of social contributions. “The government goes after the first and ignores the second,” he said.

Benefit fraud is a hot topic in France. A parliamentary report in June claimed that the government was losing €20 billion a year in fraud and undeclared income.

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

HEALTH

Weight loss drug killed at least 1,300: study

Mediator, a drug licensed for use by diabetics that became widely prescribed in France as a slimming aid, "probably" caused at least 1,300 deaths before it was withdrawn, a study published on Thursday said.

Mahmoud Zureik of the National Institute of Health and Medical Research (Inserm), who co-led the probe, told AFP that around 3,100 people had required hospitalisation during the 33 years during which the drug was sold.

However, these figures could well be an “underestimate,” he said.

The study, appearing in the specialised journal Pharmacoepidemiology & Drug Safety, finetunes an estimate by Zureik in 2010 that the death toll from the scandal was between 1,000 and 2,000.

Mediator, known by its lab name as benfluorex, was initially licensed to reduce levels of fatty proteins called lipids, with the claim that it helped diabetics control their level of blood sugar.

But it also suppressed appetite, which meant it gained a secondary official use to help obese diabetics lose weight.

In fact, it was widely sold on prescription for non-diabetics wanting to slim.

In 2009, Mediator was pulled from the European market amid evidence that it damaged heart valves and caused pulmonary hypertension.

Its French manufacturer, Servier, is being probed on suspicion of dishonest practices and deception.

The new study is an extrapolation based on figures for deaths from faulty heart valves, although not from hypertension, among major users of the drug.

The main data comes from France’s national health insurance system, which said that 303,000 patients used Mediator in 2006.

According to Mediator, 145 million packets of Mediator were sold on the French market before the drug was pulled.

The Mediator case came to light after a scandal involving a similar type of anti-obesity drug, fenfluramine, in the late 1990s.

SHOW COMMENTS